SPONSORED CONTENT
TIP: When a covered entity participates with 340B ESP™ to obtain 340B pricing restoration, it is critical to monitor manufacturer policies, ESP eligibility,
More From Our Sponsor:
Visante
Visante
SPONSORED CONTENT
News of an electronic medical record (EMR) conversion often brings about palpable anxiety and anticipation as a covered entity (CE) or health system braces itself for an enormous amount of change and new and improved avenues for patient care. These
…
Q: Where did you grow up?
I grew up in Tampa, FL.
Q: Where did you go to college/graduate school?
I completed my undergraduate studies at the University of South Florida and pharmacy school at Nova Southeastern University.
Q: What are your favorites?
Food: Mexican and Italian foods are my favorite.
Movie: My favorite movies
…
SPONSORED CONTENT
TIP: Want to resolve negative 340B accumulations to improve your organization’s 340B compliance? Simplify your process for refunding manufacturers with the Apexus Covered
SPONSORED CONTENT
Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to
…
SPONSORED CONTENT
TIP: Make sure your 340B team is highly trained and adequately staffed.
Take advantage of any and
SPONSORED CONTENT
TIP: When offering repayment to manufacturers for noncompliant purchases, it helps to standardize the refund process by setting a target date for completion,
SPONSORED CONTENT
TIP: Ensure your 340B program has established ordering procedures and practices to optimize replenishment for maximum cost savings.
SPONSORED CONTENT
TIP: It is critical to ensure that ONLY items your Covered Entity (CE) considers eligible are included in the data file that is
SPONSORED CONTENT
TIP: For any covered entities with a contract pharmacy program, it is critical to review carve-out/ineligible claims data from your TPA system(s) to
×
*Sign up for news summaries and alerts from 340B Report